Label: LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - CLAIRE 1- octinoxate liquid
LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - CLAIRE 2- octinoxate liquid
LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - CLAIRE 3- octinoxate liquid
LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - CLAIRE 4- octinoxate liquid
LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - MEDIUM 5- octinoxate liquid
LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - MEDIUM 6- octinoxate liquid
LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - MEDIUM 7- octinoxate liquid
LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - OBSCURE 8- octinoxate liquid
LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - OBSCURE 9- octinoxate liquid
-
Contains inactivated NDC Code(s)
NDC Code(s): 13537-560-01, 13537-560-02, 13537-561-01, 13537-561-02, view more13537-562-01, 13537-562-02, 13537-563-01, 13537-563-02, 13537-564-01, 13537-564-02, 13537-565-01, 13537-565-02, 13537-566-01, 13537-566-02, 13537-567-01, 13537-567-02, 13537-568-01, 13537-568-02 - Packager: Ventura Corporation LTD.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph not final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated May 9, 2013
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active Ingredients
- Purpose
- Uses
- Warnings
- Directions
- Other information
-
Inactive ingredients
Aqua (water), cyclomethicone, cyclopentasiloxane, cyclohexasiloxane, sodium chloride, peg/ppg-18/18 dimethicone, dimethicone, nylon-12 fluorescent brightener 230 salt, dimethiconol, diazolidinyl urea, methicone, cetearyl dimethicone crosspolymer, methylparaben, parfum (fragrance), propylparaben, polyvinylalcohol crosspolymer, sodium hyaluronate
May contain: CI 77891 (titanium dioxide), CI 77492 (iron oxides), CI 77491 (iron oxides), CI 77499 (iron oxides). - SPL UNCLASSIFIED SECTION
- PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - CLAIRE 1
- PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - CLAIRE 2
- PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - CLAIRE 3
- PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - CLAIRE 4
- PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - MEDIUM 5
- PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - MEDIUM 6
- PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - MEDIUM 7
- PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - OBSCURE 8
- PRINCIPAL DISPLAY PANEL - 30 ml Bottle Box - OBSCURE 9
-
INGREDIENTS AND APPEARANCE
LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - CLAIRE 1
octinoxate liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13537-560 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.07 g in 1 mL Inactive Ingredients Ingredient Name Strength water (UNII: 059QF0KO0R) cyclomethicone (UNII: NMQ347994Z) cyclomethicone 5 (UNII: 0THT5PCI0R) cyclomethicone 6 (UNII: XHK3U310BA) sodium chloride (UNII: 451W47IQ8X) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) dimethicone (UNII: 92RU3N3Y1O) diazolidinyl urea (UNII: H5RIZ3MPW4) methylparaben (UNII: A2I8C7HI9T) propylparaben (UNII: Z8IX2SC1OH) hyaluronate sodium (UNII: YSE9PPT4TH) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide yellow (UNII: EX438O2MRT) ferric oxide red (UNII: 1K09F3G675) ferrosoferric oxide (UNII: XM0M87F357) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13537-560-02 1 in 1 BOX 1 NDC:13537-560-01 30 mL in 1 BOTTLE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 05/07/2013 LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - CLAIRE 2
octinoxate liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13537-561 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.07 g in 1 mL Inactive Ingredients Ingredient Name Strength water (UNII: 059QF0KO0R) cyclomethicone (UNII: NMQ347994Z) cyclomethicone 5 (UNII: 0THT5PCI0R) cyclomethicone 6 (UNII: XHK3U310BA) sodium chloride (UNII: 451W47IQ8X) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) dimethicone (UNII: 92RU3N3Y1O) diazolidinyl urea (UNII: H5RIZ3MPW4) methylparaben (UNII: A2I8C7HI9T) propylparaben (UNII: Z8IX2SC1OH) hyaluronate sodium (UNII: YSE9PPT4TH) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide yellow (UNII: EX438O2MRT) ferric oxide red (UNII: 1K09F3G675) ferrosoferric oxide (UNII: XM0M87F357) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13537-561-02 1 in 1 BOX 1 NDC:13537-561-01 30 mL in 1 BOTTLE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 05/07/2013 LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - CLAIRE 3
octinoxate liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13537-562 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.07 g in 1 mL Inactive Ingredients Ingredient Name Strength water (UNII: 059QF0KO0R) cyclomethicone (UNII: NMQ347994Z) cyclomethicone 5 (UNII: 0THT5PCI0R) cyclomethicone 6 (UNII: XHK3U310BA) sodium chloride (UNII: 451W47IQ8X) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) dimethicone (UNII: 92RU3N3Y1O) diazolidinyl urea (UNII: H5RIZ3MPW4) methylparaben (UNII: A2I8C7HI9T) propylparaben (UNII: Z8IX2SC1OH) hyaluronate sodium (UNII: YSE9PPT4TH) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide yellow (UNII: EX438O2MRT) ferric oxide red (UNII: 1K09F3G675) ferrosoferric oxide (UNII: XM0M87F357) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13537-562-02 1 in 1 BOX 1 NDC:13537-562-01 30 mL in 1 BOTTLE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 05/07/2013 LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - CLAIRE 4
octinoxate liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13537-563 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.07 g in 1 mL Inactive Ingredients Ingredient Name Strength water (UNII: 059QF0KO0R) cyclomethicone (UNII: NMQ347994Z) cyclomethicone 5 (UNII: 0THT5PCI0R) cyclomethicone 6 (UNII: XHK3U310BA) sodium chloride (UNII: 451W47IQ8X) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) dimethicone (UNII: 92RU3N3Y1O) diazolidinyl urea (UNII: H5RIZ3MPW4) methylparaben (UNII: A2I8C7HI9T) propylparaben (UNII: Z8IX2SC1OH) hyaluronate sodium (UNII: YSE9PPT4TH) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide yellow (UNII: EX438O2MRT) ferric oxide red (UNII: 1K09F3G675) ferrosoferric oxide (UNII: XM0M87F357) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13537-563-02 1 in 1 BOX 1 NDC:13537-563-01 30 mL in 1 BOTTLE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 05/07/2013 LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - MEDIUM 5
octinoxate liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13537-564 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.07 g in 1 mL Inactive Ingredients Ingredient Name Strength water (UNII: 059QF0KO0R) cyclomethicone (UNII: NMQ347994Z) cyclomethicone 5 (UNII: 0THT5PCI0R) cyclomethicone 6 (UNII: XHK3U310BA) sodium chloride (UNII: 451W47IQ8X) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) dimethicone (UNII: 92RU3N3Y1O) diazolidinyl urea (UNII: H5RIZ3MPW4) methylparaben (UNII: A2I8C7HI9T) propylparaben (UNII: Z8IX2SC1OH) hyaluronate sodium (UNII: YSE9PPT4TH) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide yellow (UNII: EX438O2MRT) ferric oxide red (UNII: 1K09F3G675) ferrosoferric oxide (UNII: XM0M87F357) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13537-564-02 1 in 1 BOX 1 NDC:13537-564-01 30 mL in 1 BOTTLE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 05/07/2013 LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - MEDIUM 6
octinoxate liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13537-565 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.07 g in 1 mL Inactive Ingredients Ingredient Name Strength water (UNII: 059QF0KO0R) cyclomethicone (UNII: NMQ347994Z) cyclomethicone 5 (UNII: 0THT5PCI0R) cyclomethicone 6 (UNII: XHK3U310BA) sodium chloride (UNII: 451W47IQ8X) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) dimethicone (UNII: 92RU3N3Y1O) diazolidinyl urea (UNII: H5RIZ3MPW4) methylparaben (UNII: A2I8C7HI9T) propylparaben (UNII: Z8IX2SC1OH) hyaluronate sodium (UNII: YSE9PPT4TH) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide yellow (UNII: EX438O2MRT) ferric oxide red (UNII: 1K09F3G675) ferrosoferric oxide (UNII: XM0M87F357) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13537-565-02 1 in 1 BOX 1 NDC:13537-565-01 30 mL in 1 BOTTLE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 05/07/2013 LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - MEDIUM 7
octinoxate liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13537-566 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.07 g in 1 mL Inactive Ingredients Ingredient Name Strength water (UNII: 059QF0KO0R) cyclomethicone (UNII: NMQ347994Z) cyclomethicone 5 (UNII: 0THT5PCI0R) cyclomethicone 6 (UNII: XHK3U310BA) sodium chloride (UNII: 451W47IQ8X) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) dimethicone (UNII: 92RU3N3Y1O) diazolidinyl urea (UNII: H5RIZ3MPW4) methylparaben (UNII: A2I8C7HI9T) propylparaben (UNII: Z8IX2SC1OH) hyaluronate sodium (UNII: YSE9PPT4TH) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide yellow (UNII: EX438O2MRT) ferric oxide red (UNII: 1K09F3G675) ferrosoferric oxide (UNII: XM0M87F357) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13537-566-02 1 in 1 BOX 1 NDC:13537-566-01 30 mL in 1 BOTTLE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 05/07/2013 LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - OBSCURE 8
octinoxate liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13537-567 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.07 g in 1 mL Inactive Ingredients Ingredient Name Strength water (UNII: 059QF0KO0R) cyclomethicone (UNII: NMQ347994Z) cyclomethicone 5 (UNII: 0THT5PCI0R) cyclomethicone 6 (UNII: XHK3U310BA) sodium chloride (UNII: 451W47IQ8X) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) dimethicone (UNII: 92RU3N3Y1O) diazolidinyl urea (UNII: H5RIZ3MPW4) methylparaben (UNII: A2I8C7HI9T) propylparaben (UNII: Z8IX2SC1OH) hyaluronate sodium (UNII: YSE9PPT4TH) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide yellow (UNII: EX438O2MRT) ferric oxide red (UNII: 1K09F3G675) ferrosoferric oxide (UNII: XM0M87F357) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13537-567-02 1 in 1 BOX 1 NDC:13537-567-01 30 mL in 1 BOTTLE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 05/07/2013 LBEL EFFET PARFAIT FILLING EFFECT FOUNDATION SPF 10 - OBSCURE 9
octinoxate liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13537-568 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.07 g in 1 mL Inactive Ingredients Ingredient Name Strength water (UNII: 059QF0KO0R) cyclomethicone (UNII: NMQ347994Z) cyclomethicone 5 (UNII: 0THT5PCI0R) cyclomethicone 6 (UNII: XHK3U310BA) sodium chloride (UNII: 451W47IQ8X) peg/ppg-18/18 dimethicone (UNII: 9H0AO7T794) dimethicone (UNII: 92RU3N3Y1O) diazolidinyl urea (UNII: H5RIZ3MPW4) methylparaben (UNII: A2I8C7HI9T) propylparaben (UNII: Z8IX2SC1OH) hyaluronate sodium (UNII: YSE9PPT4TH) titanium dioxide (UNII: 15FIX9V2JP) ferric oxide yellow (UNII: EX438O2MRT) ferric oxide red (UNII: 1K09F3G675) ferrosoferric oxide (UNII: XM0M87F357) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13537-568-02 1 in 1 BOX 1 NDC:13537-568-01 30 mL in 1 BOTTLE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 05/07/2013 Labeler - Ventura Corporation LTD. (602751344) Establishment Name Address ID/FEI Business Operations Bel Star S.A. (Colombia) 880160197 MANUFACTURE(13537-560, 13537-561, 13537-562, 13537-563, 13537-564, 13537-565, 13537-566, 13537-567, 13537-568)
